| Model Name | Description |
| MethA | A BALB/c fibrosarcoma model induced by methylcholanthrene, commonly used for immune-modulation and checkpoint inhibitor studies. |
| WEHI-164 | A BALB/c fibrosarcoma line with moderate immunogenicity, supporting evaluation of immunotherapies and cytotoxic agents. |
| Sa1N | A BALB/c soft-tissue sarcoma model with reliable tumour growth, frequently used for immuno-oncology screening. |
| CMS5 | A BALB/c fibrosarcoma model with defined neoantigens and higher immunogenicity, useful for T-cell–based therapy research. |
| KP sarcoma | A Kras- and p53-driven C57BL/6 soft-tissue sarcoma model that reflects genetically driven sarcoma biology in an intact immune system. |